While challenges exist, we see several positive signals that give us strong reasons to remain positive and optimistic about 2023.
One example was this year’s ASHP Mid-year Clinical Meeting and Exhibition, held in Las Vegas and attended by more than 22,000 pharmacy professionals. The exhibition and the conference program demonstrated an increased focus on preventing Drug Diversion and improving quality control of prepared medications. At the last ASHP meeting three years ago, one key focus area was related to preventing bacterial contamination of prepared medication. That topic was barely mentioned at this year’s meeting. Rather, there was a shift in interest towards the business areas where we have efficient solutions to offer, such as DrugLog, WasteLog and PrepLog.
Not only did our WasteLog product receive a lot of attention, but DrugLog also generated significant interest, as it is the only validated and clinically implemented device for true quality control of compounded medication. We do indeed see an increased demand for Pharmacolog solutions in the marketplace despite the combination of a healthcare system under pressure and a year marked by conflict and increasing uncertainty.
This year was undoubtedly challenging, and we are proud to celebrate our collective achievements. We thank you all for your confidence and support in our company and our solutions. We look forward to continuing to work with you in 2023 to improve patient care worldwide.
We wish you and your loved ones all the best during this holiday season and a prosperous, happy, peaceful, and healthy 2023.
Mats Högberg, CEO of Pharmacolog
Uppsala, December 2022